Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Burbank › NPI 1336173269
Hospital

Providence Health System - Southern California

Providence Health System - Southern California was paid $21.99M by Medicaid between Jan 2018 and Dec 2024, across 301 billing codes. Its largest line is 0450, Emergency room services — 24% of everything it billed.

33Billing provider infoPROVIDENCE HEALTH SYSTEM - SOUTHERN CALIFORNIA
BURBANK, CA 91505
33aNPI1336173269assigned 07/10/2006
28Total paid$21.99M
24GClaims871,277
24DCodes billed301
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#115 of 410
Median peer was paid$6.90M
This provider vs. median3.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018138,741$2.91M
2019115,197$3.98M
202082,841$1.59M
2021106,258$2.29M
2022119,462$3.51M
2023155,625$4.00M
2024incomplete153,153$3.71M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0450 Emergency room services 24% 103,445 94,506 $5.38M
99281 Emergency department visit for the evaluation and management, self-limited or minor 6.2% 11,161 10,054 $1.37M
70450 Computed tomography, head or brain; without contrast material 4.3% 8,875 8,612 $953K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.8% 5,032 4,735 $844K
80053 Comprehensive metabolic panel 3.4% 32,447 29,600 $757K
74176 Computed tomography, abdomen and pelvis; without contrast material 3.4% 7,241 7,123 $741K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.3% 4,334 4,155 $719K
0202U Oncology (prostate), multianalyte, gene expression profiling 3.1% 6,428 6,270 $690K
99199 Unlisted special service, procedure or report 2.3% 10,542 9,233 $512K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.3% 19,171 18,068 $500K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.2% 26,169 24,697 $481K
80048 Basic metabolic panel (calcium, ionized) 1.9% 25,858 23,913 $427K
289 more codes
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.8% 58,416 $406K
71045 Radiologic examination, chest; single view 1.7% 22,821 $365K
96375 Therapeutic injection; each additional sequential IV push 1.5% 17,703 $334K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.4% 6,543 $316K
99284 Emergency room visit (serious) 1.4% 4,151 $314K
76705 Ultrasound, abdominal, real time with image documentation; limited 1.2% 4,176 $273K
96361 Intravenous infusion, hydration; each additional hour 1.2% 11,771 $257K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.1% 7,231 $249K
Z7502 1.1% 6,986 $246K
0160 1.1% 3,027 $238K
0214 1.1% 108 $235K
71046 Radiologic examination, chest; 2 views 1.0% 8,696 $231K
0762 1.0% 3,100 $222K
99283 Emergency room visit (moderate) <1% 3,753 $206K
0121 <1% 194 $204K
71275 Computed tomographic angiography, chest, with contrast material <1% 1,354 $174K
84484 <1% 21,434 $166K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 10,821 $151K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 3,406 $136K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 5,796 $119K
81001 <1% 21,833 $117K
70496 <1% 860 $99K
83690 <1% 14,426 $98K
0250 <1% 18,855 $97K
Z9725 <1% 2,903 $87K
83880 <1% 6,203 $87K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 7,315 $87K
76830 Ultrasound, transvaginal <1% 2,429 $83K
J7030 Infusion, normal saline solution , 1000 cc <1% 11,073 $74K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 3,828 $70K
70486 <1% 722 $66K
78815 Positron emission tomography (PET) for limited area imaging <1% 172 $66K
81003 <1% 14,497 $65K
72100 <1% 2,364 $65K
70551 Magnetic resonance imaging, brain; without contrast material <1% 402 $64K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 2,070 $64K
87086 Culture, bacterial; quantitative colony count, urine <1% 7,860 $61K
J3490 Unclassified drugs <1% 14,548 $59K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 14,571 $58K
84703 <1% 8,951 $56K
87040 <1% 6,348 $55K
93971 <1% 903 $55K
J2270 Injection, morphine sulfate, up to 10 mg <1% 9,466 $52K
70498 <1% 601 $52K
96376 <1% 4,681 $52K
73630 <1% 2,000 $50K
72125 Computed tomography, cervical spine; without contrast material <1% 389 $49K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 2,122 $48K
73610 <1% 2,147 $47K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 4,073 $46K
73562 <1% 2,196 $45K
J7050 Infusion, normal saline solution, 250 cc <1% 3,132 $43K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 2,295 $41K
90715 <1% 1,575 $38K
72040 <1% 1,252 $38K
59025 Fetal non-stress test <1% 4,708 $38K
73130 <1% 1,301 $38K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 9,680 $37K
73030 <1% 1,772 $36K
85379 <1% 3,703 $36K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 3,460 $35K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 273 $34K
84443 Thyroid stimulating hormone (TSH) <1% 2,712 $32K
84702 <1% 3,199 $31K
0710 <1% 3,024 $30K
80143 <1% 1,458 $29K
80179 <1% 1,440 $29K
0761 <1% 1,917 $28K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,409 $28K
73110 <1% 942 $27K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 891 $26K
J1815 Injection, insulin, per 5 units <1% 1,974 $26K
87081 <1% 3,275 $24K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 5,399 $24K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,325 $24K
96367 <1% 1,084 $24K
83605 <1% 3,957 $24K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,243 $24K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 4,422 $24K
0760 <1% 1,761 $22K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 685 $22K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 611 $20K
85610 <1% 4,980 $20K
0122 <1% 267 $18K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 1,461 $18K
97162 <1% 667 $17K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 3,073 $16K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 1,056 $16K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 1,273 $16K
73140 <1% 714 $15K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,898 $15K
0260 <1% 205 $14K
83735 <1% 3,390 $14K
71250 <1% 238 $13K
74018 <1% 761 $13K
J2060 Injection, lorazepam, 2 mg <1% 2,672 $13K
86901 <1% 4,651 $13K
0370 <1% 701 $13K
71101 <1% 365 $12K
84145 <1% 1,292 $12K
87077 <1% 1,879 $12K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,132 $12K
87186 <1% 2,147 $12K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,079 $12K
77067 Screening mammography, bilateral, including computer-aided detection <1% 393 $11K
86900 <1% 4,707 $11K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 82 $11K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 992 $11K
0270 <1% 10,045 $10K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 73 $10K
86850 <1% 2,696 $10K
85055 <1% 977 $10K
77336 <1% 368 $10K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,052 $10K
85730 <1% 2,388 $10K
80061 Lipid panel <1% 1,283 $9K
0335 <1% 395 $9K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,815 $9K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,759 $9K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 99 $8K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,702 $8K
86140 <1% 1,918 $8K
36415 Collection of venous blood by venipuncture <1% 6,351 $8K
87631 <1% 197 $8K
0360 <1% 797 $7K
76870 <1% 150 $7K
J2704 Injection, propofol, 10 mg <1% 1,778 $7K
73502 <1% 339 $7K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 151 $7K
85652 <1% 1,635 $6K
80076 <1% 550 $6K
J3370 Injection, vancomycin hcl, 500 mg <1% 573 $6K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,074 $6K
73590 <1% 203 $6K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 130 $6K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 1,964 $6K
97161 <1% 163 $5K
73080 <1% 163 $5K
P9016 Red blood cells, leukocytes reduced, each unit <1% 62 $5K
0272 <1% 1,112 $5K
86141 <1% 856 $5K
G0378 Hospital observation service, per hour <1% 207 $5K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 757 $5K
0171 Inj, epinephrine (belcher) <1% 330 $5K
85027 <1% 1,881 $4K
76801 <1% 143 $4K
Z7610 <1% 555 $4K
97116 <1% 763 $4K
0023 Pin srv add 30 min pr m <1% 22 $4K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,329 $4K
87807 <1% 976 $4K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,445 $4K
82550 <1% 586 $3K
S0164 Injection, pantoprazole sodium, 40 mg <1% 357 $3K
77063 Screening digital breast tomosynthesis, bilateral <1% 299 $3K
J1650 Injection, enoxaparin sodium, 10 mg <1% 717 $3K
93970 <1% 42 $3K
0301 <1% 1,314 $3K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 14 $3K
73560 <1% 148 $3K
J1953 Injection, levetiracetam, 10 mg <1% 175 $3K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,876 $3K
84439 <1% 455 $3K
76641 <1% 69 $3K
J3475 Injection, magnesium sulfate, per 500 mg <1% 359 $3K
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 441 $3K
0324 <1% 659 $3K
77300 <1% 26 $2K
86920 <1% 62 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 428 $2K
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 6,175 $2K
0258 <1% 799 $2K
0940 <1% 335 $2K
80047 <1% 301 $2K
85014 <1% 338 $2K
J1630 Injection, haloperidol, up to 5 mg <1% 266 $2K
87210 <1% 297 $2K
0300 <1% 2,168 $2K
72170 <1% 91 $2K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 162 $2K
A9585 Injection, gadobutrol, 0.1 ml <1% 129 $2K
0042T <1% 15 $2K
29125 <1% 29 $1K
0510 <1% 614 $1K
J1644 Injection, heparin sodium, per 1000 units <1% 571 $1K
82077 <1% 42 $1K
87147 <1% 111 $1K
87205 <1% 414 $1K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 124 $1K
J1453 Injection, fosaprepitant, 1 mg <1% 21 $1K
96417 <1% 171 $1K
0352 <1% 629 $1K
72131 <1% 13 $1K
J1836 Injection, metronidazole, 10 mg <1% 124 $1K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 12 $971.54
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 263 $925.55
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 24 $924.28
88342 <1% 103 $848.69
92610 <1% 52 $833.93
A9270 Non-covered item or service <1% 936 $814.66
12001 <1% 124 $787.46
93880 <1% 12 $753.28
93017 <1% 28 $722.35
29515 <1% 115 $710.61
86308 <1% 161 $708.32
J7120 Ringers lactate infusion, up to 1000 cc <1% 207 $687.86
76376 <1% 47 $676.31
76770 <1% 16 $661.26
87070 <1% 154 $635.95
J0780 Injection, prochlorperazine, up to 10 mg <1% 173 $625.49
0361 <1% 35 $613.50
72072 <1% 15 $601.23
77066 Tomosynthesis, mammo <1% 13 $587.73
C1769 Guide wire <1% 12 $566.61
92526 <1% 28 $533.32
82803 <1% 35 $523.72
0637 <1% 963 $518.25
0350 <1% 62 $502.90
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 13 $480.80
0636 <1% 3,607 $474.17
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 293 $469.30
86592 <1% 90 $464.92
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 12 $403.88
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 53 $403.28
Z9727 <1% 13 $390.00
J0360 Injection, hydralazine hcl, up to 20 mg <1% 127 $377.82
A4649 Surgical supply; miscellaneous <1% 413 $367.49
84100 <1% 191 $363.58
77080 <1% 12 $322.95
12011 <1% 28 $321.60
96415 <1% 37 $316.37
82140 <1% 42 $302.94
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 80 $270.72
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 90 $270.25
71010 <1% 40 $269.52
10061 <1% 12 $234.75
88307 <1% 25 $220.06
76642 <1% 12 $218.93
29130 <1% 39 $186.37
82728 <1% 43 $186.08
81025 <1% 51 $179.53
71020 <1% 17 $177.79
73090 <1% 12 $168.61
12002 <1% 24 $144.38
J0456 Injection, azithromycin, 500 mg <1% 45 $139.02
J1920 Injection, labetalol hydrochloride, 5 mg <1% 61 $122.23
87899 <1% 18 $120.80
82247 <1% 35 $109.34
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg <1% 81 $106.66
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 39 $104.05
0306 <1% 1,171 $102.62
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 539 $100.55
0351 <1% 336 $95.49
J2470 Injection, pantoprazole sodium, 40 mg <1% 40 $90.79
A4217 Sterile water/saline, 500 ml <1% 18 $81.49
J0692 Injection, cefepime hydrochloride, 500 mg <1% 25 $75.93
29505 <1% 12 $75.19
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) <1% 159 $73.53
J1171 Injection, hydromorphone, 0.1 mg <1% 36 $73.14
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 28 $62.15
99152 <1% 12 $56.65
83615 <1% 12 $49.44
84550 <1% 26 $48.75
96040 <1% 27 $34.80
82009 <1% 13 $32.39
0730 <1% 303 $29.84
82248 <1% 14 $21.28
99153 Mod sedat endo service >5yrs <1% 29 $21.12
J1940 Injection, furosemide, up to 20 mg <1% 17 $18.89
0305 <1% 1,092 $18.76
81002 <1% 13 $7.89
0307 <1% 461 $4.06
Q5001 Hospice or home health care provided in patient's home/residence <1% 34 $0.06
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 162 $0.01
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 151 $0.01
0424 0% 92 $0.00
0302 0% 820 $0.00
0278 0% 39 $0.00
0402 0% 65 $0.00
0320 0% 14 $0.00
15853 0% 13 $0.00
S9445 Patient education, not otherwise classified, non-physician provider, individual, per session 0% 1,846 $0.00
0410 0% 649 $0.00
0771 0% 296 $0.00
0310 0% 45 $0.00
0720 0% 115 $0.00
0420 0% 91 $0.00
0255 0% 47 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 26 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialANDERSON, DONALD (ASSISTANT SECRETARY ENROLLMENTS)
Same official

Other billing entities under ANDERSON, DONALD

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.